Waldencast PLC

More Details of Waldencast PLC Company

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. Obagi Medical sells skin care products which are formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, wrinkles, and to protect and enhance skin tone and texture. It offers over 125 products in the United States through various channels. The Milk Makeup segment is a makeup brand which offers a selection of both makeup and skincare products. Its products include Matte Bronzer, Hydro Grip Set + Refresh Spray, Kush Mascara, Kush Brow, Water Jelly Tint, and Hydro Grip Primer. Milk Makeup offers over 250 products through its United States Website, www.MilkMakeup.com, and its retail partners, including Sephora in North America, Europe, the Middle East, Australia, Cult Beauty, and ASOS online.

Company Info

Company codeWALD

Company nameWaldencast PLC

IPO dateMar 18, 2021

Founded at2020

CEOMr. Michel Brousset

Number of employees332

Security typeOrdinary Share

Fiscal year-endMar 18

Address81 Fulham Road

CityLONDON

Stock exchangeNASDAQ Capital Market Consolidated

CountryUnited Kingdom

Postal codeSW3 6RD

Phone4402031960264

Websitehttps://www.waldencast.com/

Company codeWALD

IPO dateMar 18, 2021

Founded at2020

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Mr. Manuel Manfredi

Chief Financial Officer

--

Mr. Simon Dailley

Director

--

Mr. Zachary (Zack) Werner

Independent Director

--

Ms. Kelly Brookie

Independent Director

--

Mr. Felipe Dutra

Executive Chairman of the Board

--

Name

Name/Position

Position

Shareholding

Change

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Mr. Manuel Manfredi

Chief Financial Officer

--

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2023

FY2022

FY2022Q2

FY2022Q1

FY2021

FY2021Q4

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

By RegionUSD

Name

Revenue

Proportion

North America

202.26M

75.09%

Rest of the World

67.11M

24.91%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

Shareholder

Update time: Wed, Apr 16

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Cedarwalk Skincare Ltd

25.56%

Zeno Equity Partners LLP

13.01%

Arbitrage Ltd

8.92%

Waldencast Long-Term Capital LLC

8.31%

Burwell Mountain Trust

7.00%

Other

37.19%

Shareholder Statistics

Shareholder

Proportion

Cedarwalk Skincare Ltd

25.56%

Zeno Equity Partners LLP

13.01%

Arbitrage Ltd

8.92%

Waldencast Long-Term Capital LLC

8.31%

Burwell Mountain Trust

7.00%

Other

37.19%

Type

Shareholder

Proportion

Corporation

54.55%

Hedge Fund

13.17%

Private Equity

5.43%

Investment Advisor

4.64%

Individual Investor

2.70%

Investment Advisor/Hedge Fund

1.86%

Research Firm

0.33%

Bank and Trust

0.04%

Pension Fund

0.02%

Other

17.26%

Institutional Shareholding

Update time: Tue, Mar 4

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

144

92.73M

82.76%

-923.07K

2024Q4

144

78.12M

69.70%

-17.61M

2024Q3

135

86.17M

77.32%

-10.93M

2024Q2

172

87.50M

78.73%

-27.82M

2024Q1

176

82.86M

81.85%

-41.80M

2023Q4

166

82.66M

81.66%

-28.79M

2023Q3

155

85.92M

95.07%

-24.54M

2023Q2

141

83.77M

96.89%

-26.04M

2023Q1

107

83.33M

96.42%

-27.69M

2022Q4

106

83.16M

96.22%

-27.74M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Cedarwalk Skincare Ltd

28.64M

25.56%

--

Apr 15, 2024

Zeno Equity Partners LLP

15.34M

13.69%

--

Dec 31, 2024

Waldencast Long-Term Capital LLC

9.31M

8.31%

-7.99M

-46.19%

Nov 19, 2024

Burwell Mountain Trust

7.85M

7%

--

Apr 15, 2024

Main Post Partners, L.P.

6.09M

5.43%

+6.09M

--

Apr 15, 2024

Brousset (Michel)

2.90M

2.59%

--

Apr 15, 2024

Milestones Administradora de Recursos Ltda.

2.20M

1.96%

--

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

1.22M

1.09%

+17.64K

+1.46%

Dec 31, 2024

Related ETFs

Update time: Fri, May 2

Name

Proportion

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0%

Proshares Ultra Russell 2000

0%

Avantis US Small Cap Equity ETF

0%

ProShares UltraPro Russell2000

0%

iShares Russell 3000 ETF

0%

Global X Russell 2000 Covered Call ETF

0%

iShares Russell 2000 ETF

0%

ProShares Hedge Replication ETF

0%

iShares Russell 2000 Value ETF

Proportion0.01%

Global X Russell 2000 ETF

Proportion0%

Proshares Ultra Russell 2000

Proportion0%

Avantis US Small Cap Equity ETF

Proportion0%

ProShares UltraPro Russell2000

Proportion0%

iShares Russell 3000 ETF

Proportion0%

Global X Russell 2000 Covered Call ETF

Proportion0%

iShares Russell 2000 ETF

Proportion0%

ProShares Hedge Replication ETF

Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

2.720USD

Waldencast PLC

2.720

Overview

Company